Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Inoculation of Bioreactors – V 2.0

Posted on By


Biosimilars: SOP for Inoculation of Bioreactors – V 2.0


Standard Operating Procedure for Inoculation of Bioreactors in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/067/2025
Supersedes SOP/BS/067/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standardized procedure for inoculating bioreactors under aseptic conditions with qualified seed culture in biosimilar manufacturing, ensuring culture viability and contamination control.

2. Scope

This SOP applies to inoculation of stainless steel or single-use bioreactors ranging from 10L to 2000L, used for mammalian cell culture in upstream biosimilar production processes.

3. Responsibilities

  • Upstream Process Operators: Conduct inoculation and record all parameters.
  • Process Development Scientists: Approve seed culture quality and density for inoculation.
  • QA Personnel: Verify environmental monitoring and documentation before and after inoculation.

4. Accountability

The Upstream Production Manager is accountable for ensuring that inoculation is performed under GMP conditions, using validated materials and equipment.

5. Procedure

5.1 Seed Culture Qualification

  1. Confirm seed culture from spinner flask has VCD ≥ 1.0 × 10⁶ cells/mL and viability ≥ 90%.
  2. Check for contamination indicators and record results in Seed Culture Log (Annexure-1).

5.2 Bioreactor Readiness

  1. Verify that bioreactor sterilization (SIP or autoclave) is completed and filter integrity is confirmed.
  2. Check media temperature (typically 36.5–37.5°C), pH (6.8–7.2), DO (setpoint 40–50%), and agitation speed.
  3. Ensure vessel is labeled and configured as per batch record (Annexure-2).

5.3 Aseptic Inoculation

  1. Perform inoculation inside Grade A/B environment or using sterile connection system (e.g., sterile weld or CPC connector).
  2. Connect seed culture bag or transfer tubing aseptically to bioreactor inlet port.
  3. Slowly transfer inoculum using gravity feed or peristaltic pump, avoiding shear or foaming.
  4. Verify complete transfer and rinse transfer line with small volume of media if required.

5.4 Post-Inoculation Monitoring

  1. Start agitation and monitor pH, DO, and temperature parameters continuously.
  2. Take a sample 1 hour post-inoculation to check initial VCD, viability, and osmolality.
  3. Perform microbial sampling of environment and personnel per SOP/BS/043/2025.

5.5 Documentation and Control

  1. Record all inoculation data including transfer volume, time, method, and operator in Annexure-3.
  2. Attach seed culture CoA and filter integrity reports to batch record.

6. Abbreviations

  • VCD: Viable Cell Density
  • SIP: Steam-In-Place
  • DO: Dissolved Oxygen
  • GMP: Good Manufacturing Practice

7. Documents

  1. Seed Culture Qualification Log – Annexure-1
  2. Bioreactor Readiness Checklist – Annexure-2
  3. Inoculation Activity Log – Annexure-3

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • SOP/BS/043/2025 – Microbiological Environmental Monitoring

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Seed Culture Qualification Log

Date Flask ID VCD (×10⁶/mL) Viability (%) Contamination Status
03/05/2025 SPF-002 1.1 91 Clear

Annexure-2: Bioreactor Readiness Checklist

Parameter Target Actual Status
Temperature 37°C 36.9°C OK
pH 7.0 ± 0.2 7.1 OK
DO 45% 44.8% OK

Annexure-3: Inoculation Activity Log

Date Bioreactor ID Seed Volume (L) Transfer Method Operator
04/05/2025 BR-100L 5.0 Sterile Weld Rajesh Kumar

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added filter integrity and post-inoculation sampling requirements Compliance Update
See also  Biosimilars: SOP for Handling Genetically Modified Organisms (GMO) - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: Conductivity Method Development – V 2.0
Next Post: API Manufacturing: SOP for Analytical Balance Calibration – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version